Skip to content

Low Level Laser Light Therapy and Chronic Neck and Shoulder Pain

CompletedNot applicableNCT00929305
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study was to determine whether the application of low level laser light therapy to the neck and shoulder region is effective in reducing chronic neck and shoulder pain of musculoskeletal origin.

Study details

Official title
Study of the Effect of Low Level Laser Therapy on the Reduction of Chronic Pain Associated With Neck and Shoulder Pain of Musculoskeletal Origin.
Conditions
Interventions
  • Device: Erchonia PL2000
  • Device: Placebo laser
Sponsor
Erchonia Corporation
Start date
2001-01
Primary completion
2001-06
Sex
All
Age range
from 18 Years to 65 Years
Results posted
Yes, on ClinicalTrials.gov
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Location of pain is on the right and/or left side of the neck and/or shoulder and/or the back of the neck. * Etiology of pain is osteoarthritis/Degenerative Joint Disorder (DJD); chronic muscle spasms or cervical and thoracic spine sprain strain, determined according to subject medical history, medication use history, previous records review, physical examination of the cervical spine and shoulder. * Stage of injury is chronic, having prevailed for longer than 30 days. * Degree of Pain self-rating of 50 or greater on the 0-100 Visual Analog Scale (VAS). * 18-65 years. Exclusion Criteria: * Stage of injury is acute, having prevailed for less than 30 days. * Known herniated disc injury. * Any other disease or condition that may cause or contribute to the chronic pain condition. * Presence of infection or open wound at the treatment areas. * Use of steroids or narcotics. * Use of over-the-counter (OTC) medication for the relief of pain within the 24-hour period prior to participating in the treatment phase of the study, or prescription medication for the relief of pain within the 48-hour period prior to participating in the treatment phase of the study. * pregnant or lactating.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00929305